Original title: Shenwei Pharmaceutical (02877-HK)'s turnover in the first September fell 8.3% year on year to RMB 1,880 billion Source: Caihua.com

[Caihua News] Shenwei Pharmaceutical (02877-HK) announced that the turnover in the management accounts not reviewed by auditors for the nine months ended September 30, 2020 was RMB 1,880 million (same units below), a decrease of 8.3% from the same period in 2019. By classification, the turnover of injectable products decreased by 17.4% to 787 million yuan; the turnover of softgel products increased by 0.5% to $353 million; the turnover of granule products decreased by 7.3% to $240 million; the turnover of traditional Chinese medicine formula granular products increased 8.7% to 410 million yuan; others The turnover of dosage products decreased by 18.9% to $90 million.

For the third quarter of 2020, overall turnover recorded a 1.1% increase. Based on product dosage analysis, injectable products, softgel products, granule products and traditional Chinese medicine formula granule products accounted for about 41.9%, 18.8%, 12.8% and 21.8% of the Group's total turnover for the nine months ended September 30, 2020.